SUMMARY A 34 year old man is described with systemic lupus erythematosus and recurrent massive pleural effusions. Systemic treatment with corticosteroids and azathioprine controlled all other manifestations of the disease apart from the pleural effusions. These were finally, successfully treated by pleurectomy.
glucose, lactate dehydrogenase greater than 200 IU, lymphocytosis (predominantly T cells), low total complement levels, and the presence of immune complexes.5 It has been shown that complement fractions and immunoglobulins are present also in the pleural tissues. These pleural findings, though characteristic of the pathology of SLE, do not contribute to the American Rheumatism Association (ARA) criteria for diagnosis .6 In most cases the pleural effusions of SLE do not require special treatment and resolve quickly. 5 More persistent effusions respond rapidly to corticosteroids, combined if necessary with an immunosuppressive drug. Persistent effusions very refractory to treatment do occur in SLE, however.5 7 five months, with evidence of production of antibody in the pleura. This troublesome condition was successfully treated by pleurectomy.
Case report
A 34 year old man was transferred to the Royal Victoria Hospital, Belfast in November 1984 for treatment of a large recurrent left sided pleural effusion and active systemic lupus erythematosus (SLE). He had an eight month history of arthritis, recurrent mouth ulceration, diffuse alopecia, a photosensitive skin rash on face and arms, loss of energy, and weight loss of eight kilograms. He had developed dyspnoea on effort one month before admission, at which time 1000 ml of pleural fluid had been aspirated at another hospital. During the eight months before his admission he had had two courses of prednisolone, 20 mg daily, each lasting 14 days, which had helped his joint symptoms but not his dyspnoea.
By November 1984 he had a patchy erythematosus rash of his face and arms, diffuse mild alopecia, and a large left sided pleural effusion (Fig. 1) . Physical examination was normal, including heart and blood pressure (120/80 mmHg), and there was no evidence of cardiac failure. There was a normochromic, normocytic anaemia (haemoglobin 10-7 g/dl) (107 g/l), white cell and platelet counts being normal. Westergren erythrocyte sedimentation rate was 80 mm/lst h. Urea was slightly raised at 12 250 ml pleural fluid had been removed over five months.
In April 1985 the patient underwent thoracotomy and left parietal pleurectomy. The pleura showed multiple white nodules measuring 1 mm in diameter on its surface (Fig. 2) ; these were composed of aggregates of histiocytes and plasma cells. Immunofluorescence showed these plasma cells to be secreting immunoglobulins, predominantly IgG. Complement components Clq and C3 were demonstrated around pleural blood vessels.
Twelve months' postoperatively there has been no recurrence of the effusion. Prednisolone dosage has been reduced to 9 mg daily, and he continues on azathioprine 150 mg daily. His chest x ray shows pleural thickening at the left base (Fig. 3) .
Discussion
Although pleural involvement is common in SLE, massive recurrent effusions are rare." 7 Such effusions respond to corticosteroid and immunosuppressive treatment within weeks or months, rarely requiring thoracocentesis. In this patient unilateral pleural effusions recurred totalling more than 12 litres. Bacterial, tuberculous, fungal, and neoplastic conditions were excluded. Low complement levels and the presence of immune complexes in the pleural fluid suggested an immunopathological basis for the effusions. The effusions persisted over five months despite high doses of prednisolone and azathioprine, sufficient to control other manifestations of active SLE.
One mechanism suggested for the production of pleural effusions in SLE is the deposition of remotely generated immune complexes in the pleural capillaries, which fix complement and release split complement fractions C3a and C5a. We would speculate that the antibodies being produced might be cross reactive for anti-DNA and certain glycosaminoglycans present in pleural connective tissues, such as heparan and chondroitin sulphate, as recently suggested by Eilat for lupus nephritis. 12 If persistent pleural effusion in SLE is a purely local (pleural) phenomenon local intervention is logical. In one previous account of the treatment of massive recurrent pleural effusion successful treatment was achieved by talc poudrage.8 Bell and Lawrence have also reported two cases of chronic pleurisy in SLE, unresponsive to prednisolone and azathioprine, which were successfully treated by pleurectomy. '-3 This case report confirms that massive recurrent pleural effusions unresponsive to corticosteroids and immunosuppressive agents may occur in SLE. Pleurectomy proved successful in this case, and we would suggest that it is a logical and definitive treatment for such cases. 
